New Research Benchmarks Clinical Investigator Satisfaction with Pharma Sponsors and Central Laboratories
5-year Study Tracks Central Lab Performance and Identifies Opportunities for Pharma Sponsors to Improve Clinical Investigator Satisfaction.
Menlo Park, CA, October 24, 2016 --(PR.com)-- Life Science Strategy Group (LSSG), a leading strategic consulting firm to the CRO industry, is pleased to announce the availability of its 2016 syndicated report on Clinical Trial Investigator Satisfaction & Central Laboratory Performance. This update to its benchmark 2011 and 2013 studies provides a detailed, 5-year longitudinal look into investigator satisfaction and central laboratory performance.
Based on feedback from more than 250 clinical trial investigators globally, Covance Central Laboratory Services is the most-preferred central laboratory, exceeding 2011 levels at 60% preference share. Other leading, preferred labs include Q2 Solutions and ICON Central Laboratory. The longitudinal tracking study includes performance benchmarking scores for Covance Central Laboratory Services, Eurofins Central Laboratory, ICON Central Laboratory, PPD Central Laboratory and Q2 Solutions Central Laboratory across 17 critical evaluation criteria.
The report also provides longitudinal tracking of investigator satisfaction with clinical trial sponsors, key challenges faced by investigators, preferences for central laboratories, and opportunities to improve investigator-sponsor working relationships. According to Jon Meyer, Principal, Life Science Strategy Group, "You can’t ignore the findings...not when 98% of investigators state increasingly, the central laboratory selected by the pharma sponsor impacts their willingness to work with that sponsor in the future. We all know top investigators are in demand and Pharma is competing for them. This update to our 2011 and 2013 studies provides the granularity missing in snapshot, off-the-shelf, benchmarking studies and uncovers top opportunities where pharma sponsors can improve investigator relationships and performance.”
To learn more about the relationship between clinical trial investigator satisfaction, central laboratory preference and performance, or to download sample pages from the report, visit http://www.lifesciencestrategy.com/publications.
About Life Science Strategy Group, LLC
Life Science Strategy Group, LLC is a consultancy specializing in strategic consulting, market research engagements and syndicated publications across a variety of therapeutic, technology and service industries including contract research services, pharmaceutical, biotechnology, medical devices, diagnostics and drug discovery.
Based on feedback from more than 250 clinical trial investigators globally, Covance Central Laboratory Services is the most-preferred central laboratory, exceeding 2011 levels at 60% preference share. Other leading, preferred labs include Q2 Solutions and ICON Central Laboratory. The longitudinal tracking study includes performance benchmarking scores for Covance Central Laboratory Services, Eurofins Central Laboratory, ICON Central Laboratory, PPD Central Laboratory and Q2 Solutions Central Laboratory across 17 critical evaluation criteria.
The report also provides longitudinal tracking of investigator satisfaction with clinical trial sponsors, key challenges faced by investigators, preferences for central laboratories, and opportunities to improve investigator-sponsor working relationships. According to Jon Meyer, Principal, Life Science Strategy Group, "You can’t ignore the findings...not when 98% of investigators state increasingly, the central laboratory selected by the pharma sponsor impacts their willingness to work with that sponsor in the future. We all know top investigators are in demand and Pharma is competing for them. This update to our 2011 and 2013 studies provides the granularity missing in snapshot, off-the-shelf, benchmarking studies and uncovers top opportunities where pharma sponsors can improve investigator relationships and performance.”
To learn more about the relationship between clinical trial investigator satisfaction, central laboratory preference and performance, or to download sample pages from the report, visit http://www.lifesciencestrategy.com/publications.
About Life Science Strategy Group, LLC
Life Science Strategy Group, LLC is a consultancy specializing in strategic consulting, market research engagements and syndicated publications across a variety of therapeutic, technology and service industries including contract research services, pharmaceutical, biotechnology, medical devices, diagnostics and drug discovery.
Contact
Life Science Strategy Group, LLC
Jon Meyer
1-800-941-6373
www.lifesciencestrategy.com
Jon Meyer
1-800-941-6373
www.lifesciencestrategy.com
Contact
Categories